As far as tumor metastasis and senescence is concerned, dysregulation of Skp2 level reduces osteosarcoma cell invasion and lung metastasis both in vitro and vivo (Ding et al., 2017; Zhang et al., 2018). Here, SKP2 is linked to osteosarcoma.